October 2023 - Cambridge Cognition

Success Factors for Remote and Hybrid Decentralised Trials from Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home

26 October 2023 / Webinars

Success Factors for Remote and Hybrid Decentralised Trials From Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home About this webinar Thursday 16th November 2023 10:00-11:00 EST | 15:00-16:00 GMT Platform: Zoom Webinars Amidst the enthusiasm surrounding the advantages and efficiencies promised by Decentralised Clinical Trials (DCTs), encompassing remote […]

Success Factors for Remote and Hybrid Decentralised Trials from Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home Read More »

Launch of automated quality assurance for clinical trials

24 October 2023 / News

News Back to resource centre 24 October 2023 Launch of automated quality assurance for clinical trials Cambridge Cognition (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce the launch today of AQUA, the Company’s automated quality assurance solution for central nervous system (“CNS”) clinical trials that is powered

Launch of automated quality assurance for clinical trials Read More »

2023 CANTAB Research Grant winners announced

3 October 2023 / News

Cambridge Cognition unveils strategic partnership for Chinese market expansion Cambridge Cognition is pleased to announce an expansion in the Chinese market through a strategic partnership with Luca Healthcare Limited, a category leader in digital screening, treatment and management tools in China. Cambridge Cognition has signed an exclusive licencing agreement with Luca Healthcare

2023 CANTAB Research Grant winners announced Read More »